ArticleUltrasound in medicine & biology2025
Ultrasound-Guided Photoacoustic Monitoring of Vascular Ischemia in Implant-Induced Skin Necrosis.
Article in Ultrasound in medicine & biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Photoacoustic Imaging for Women's Gynecological Health: Advances and Clinical Prospects.Bioengineering (Basel, Switzerland) · 2026Review
- Quantitative photoacoustic tomography of skin vasculature predicts subcutaneous implant exposure.Journal of biomedical optics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveImplant-induced skin necrosis remains a significant clinical challenge in subcutaneous implant applications, believed to result from vascular ischemia caused by mechanical stress. However, this hypothesis remains largely qualitative and lacks direct quantitative validation. This study investigates the potential of ultrasound-guided photoacoustic (US/PA) imaging as a non-invasive diagnostic tool for detecting vascular changes and predicting sites of breakdown in response to subcutaneous implants.
methodsThree designs of 3-D-printed porous poly-ɛ-caprolactone implants - a unimodal cube, a bimodal cube and a unimodal dome - were implanted subcutaneously in 16 SKHl-Elite hairless mice. Longitudinal US/PA imaging was performed bi-weekly for 12 weeks to monitor PA vasculature (532 nm), vascular density (532 nm) and total hemoglobin levels (700-950 nm). Skin health was scored using a modified National Pressure Injury Advisory Panel-based system. Temporal and spatial analyses were conducted to evaluate the relationship between PA-derived biomarkers and skin health deterioration.
resultsMice with implant exposure (N = 5) exhibited a progressive decrease in PA biomarkers, with reductions of up to 48% by week 12. These changes preceded visible skin necrosis by approximately 2-4 weeks. In contrast, the healthy group (N = 11) maintained stable signals. PA vasculature at 532 nm showed the most significant temporal differentiation (p = 0.0013) and strong correlation with skin health (R >0.85). Spatial hemoglobin maps revealed that local reductions in vascularity preceded localized skin dehiscence.
conclusionUltrasound-guided PA imaging enables early, non-invasive detection of vascular compromise associated with implant-induced skin necrosis. Among the tested biomarkers, PA vasculature at 532 nm emerged as the most sensitive and practical for early detection, offering a promising tool for guiding implant design and improving post-implantation monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.